This inventor holds 1 USPTO granted patent. Top assignee: Neogene Therapeutics B.v.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Loek Josephus Eggermont: Innovator in Genetic Engineering
Introduction
Loek Josephus Eggermont is a notable inventor based in The Hague, Netherlands. He has made significant contributions to the field of genetic engineering, particularly through his innovative work on peptide markers.
Latest Patents
Loek holds a patent titled "Peptide Markers to Track Genetically Engineered Cells." This patent represents a crucial advancement in the ability to monitor genetically modified organisms, enhancing the understanding of their behavior and impact.
Career Highlights
Loek Josephus Eggermont is currently associated with Neogene Therapeutics B.V., where he applies his expertise in genetic engineering. His work at Neogene Therapeutics focuses on developing novel therapeutic solutions that leverage genetic modifications.
Collaborations
Loek collaborates with talented individuals such as Gavin M. Bendle and Thomas Kuilman. These partnerships foster a creative environment that drives innovation and enhances research outcomes.
Conclusion
Loek Josephus Eggermont is a prominent figure in the realm of genetic engineering, with a patent that showcases his innovative spirit. His contributions continue to influence the field and pave the way for future advancements.